PLX · Protalix BioTherapeutics, Inc.
$2.30
+0.08 (+3.60%)
At close · Aug 17
Market Cap
$178.87M
Shares
80.57M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.
Key facts
CIK
1006281
CUSIP
74365A309
13F (30d)
98 filings
96 filers
Visit website
Investor relations